ST. LOUIS--(BUSINESS WIRE)--The Brain Tumor Funders’ Collaborative (BTFC) today announced the award of 11 one-year feasibility grants of $100,000 each to teams of researchers and clinicians developing the types of tools needed to translate scientific discoveries into effective new treatments for brain cancer patients. The BTFC’s second joint initiative for brain tumor research is intended to accelerate the testing of different kinds of brain tumor response markers – reliable, easily monitored biological signals that can reveal if and how a tumor is responding to therapies.
